Prairie View Partners, LLC Synthetic Biologics, Inc. Transaction History

Prairie View Partners, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Jul 23, 2021	SELL	$4.6 - $7.2 $2,240 - $3,506	-487 Closed	0 $0
Q1 2021 Apr 21, 2021	BUY	$5.0 - $11.7 $2,435 - $5,697	487 New	487 $0

Ticker SYN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,844,100
Market Cap $9.51M
Description
Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile...

Get notified when there are updates to the investment portfolio of Prairie View Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Prairie View Partners, LLC with notifications on news.